Department of Breast Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China
Search for other papers by Tian Zhou in
Google Scholar
PubMed
Department of Surgery, Second People's Hospital of Guizhou Province, Guiyang, Guizhou, China
Search for other papers by Dai-wei Zhao in
Google Scholar
PubMed
Search for other papers by Ning Ma in
Google Scholar
PubMed
Search for other papers by Xue-ying Zhu in
Google Scholar
PubMed
Search for other papers by Xing-hong Chen in
Google Scholar
PubMed
Search for other papers by Xue Luo in
Google Scholar
PubMed
Search for other papers by Song Chen in
Google Scholar
PubMed
Search for other papers by Qing-jun Gao in
Google Scholar
PubMed
pathological markers and therapeutic targets and to identify them as soon as possible using the appropriate treatment. The role of forkhead box P4 (FOXP4) in THCA has not been reported. The FOXP protein family is a super-family of transcriptional regulators
Search for other papers by Camila Aparecida Moma in
Google Scholar
PubMed
Search for other papers by Icléia Siqueira Barreto in
Google Scholar
PubMed
Search for other papers by Ligia Vera Montali Assumpção in
Google Scholar
PubMed
Search for other papers by Denise Engelbrecht Zantut-Wittmann in
Google Scholar
PubMed
that a greater presence of regulatory T lymphocytes (FOXP3+) and double-negative T lymphocytes (T CD3+ CD4− CD8−) was associated with papillary carcinoma compared to Hashimoto's thyroiditis ( 23 ). Likewise, a lower risk of PTC remission was observed in
Search for other papers by Qian Yang in
Google Scholar
PubMed
Search for other papers by Wencai Ke in
Google Scholar
PubMed
Search for other papers by Fanfan Pan in
Google Scholar
PubMed
Search for other papers by Xinmei Huang in
Google Scholar
PubMed
Search for other papers by Jun Liu in
Google Scholar
PubMed
Search for other papers by Bingbing Zha in
Google Scholar
PubMed
step in thyroid hormone synthesis. Methimazole (MMI) is an established first-line therapy for GD in China and MMI-induced granulocytosis is dose-dependent ( 4 ). Antithyroid drug (ATD)-associated agranulocytosis is a rare but life-threatening event